Second Line Treatment with Bruton Tyrosine Kinase Inhibitor (BTKi) or Bcl-2 Inhibitor (Bcl2i) in Patients with Chronic Lymphocytic Leukemia (CLL): Primary Analysis of the Czech Study Group for CLL ( CSCLL)Jana Mihalyova,Anna Panovska,Martin Simkovic,Peter Turcsanyi,Martin Spacek,Martin Brejcha,Daniel Lysak,Heidi Mocikova,Sarka Pavlova,Marika Chrapava,Jana Zuchnicka,Yvona Brychtova,Pavel Vodarek,Renata Urbanova,Tereza Likarova,Jitka Malcikova,Tereza Jurkova, Klara Lancova,Lucie Bezdekova,Tomas Papajik,Jana Baranova,Tomas Arpas,Sarka Pospisilova,Lukas Smolej,Michael DoubekBLOOD（2023）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
